Production & Manufacturing
Production & Manufacturing
GSK announces positive real-world data for meningitis B vaccine in first year since UK immunisation programme
Preliminary data from the world’s first national meningitis B immunisation programme with Bexsero1, launched one year ago in the UK, shows the estimated effectiveness of the vaccine at 83 percent against any meningitis B strain and 94 percent. ...
Production & Manufacturing
Dr. Reddy’s Laboratories announces the launch of Bupropion HCl Extended-Release Tablets
Dr. Reddy’s Laboratories Ltd announced that it has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin® SR (bupropion HCl) Sustained-Release Tablets in the United States...
Production & Manufacturing
AstraZeneca enters commercialisation agreement with Aspen for  anaesthetics portfolio
AstraZeneca announced that it has completed the commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics portfolio outside the US. The agreement covers seven established medicines -...
Production & Manufacturing
TaiGen Biotechnology Out-Licenses Taigexyn® (Nemonoxacin) to Productos CientÃficos for the Latin American Market
TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Productos CientÃficos S.A. de C.V. ("PC"), a leading Mexican pharmaceutical company, to develop and commercialize Taigexyn® (nemonoxacin) in Latin America. Taigexyn® is...
Production & Manufacturing
Janssen Submits Application to U.S. FDA to Expand Indication for Daratumumab Â
Janssen Biotech, Inc. announced a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been submitted to the U.S. FDA . The application seeks to expand the current indication, using daratumumab in combination with lenalidomide (an...
Production & Manufacturing
Agilent Chooses Colorado for New Pharma Manufacturing Facility
Agilent Technologies reports that it acquired 20 acres in Weld County in northern Colorado, on which it plans to build a pharmaceutical manufacturing facility. “The products manufactured at this site will be used by our customers...
Production & Manufacturing
Alexion issued new FDA Form 483 for Rhode Island plant
The FDA has again raised issues at an Alexion plant that three years ago was issued a warning letter. The facility is where Alexion manufactures what has been deemed the world’s most expensive drug, Soliris. Alexion...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
